Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps - an Exploratory Study

NCT07046117 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT07046117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07046117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps - an Exploratory Study
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2025
Completion date
August 1, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma bronchiale, chronic rhinosinusitis with nasal polyps (crswnp)